Navigation Links
Allied Minds and The George Washington University partner to form LuxCath LLC

This medical innovation, based on collaborative research by Drs. Marco Mercader, M.D., a cardiologist; Matthew Kay, D.Sc., a biomedical engineer; and Narine Sarvazyan, Ph.D., a physiologist, at the GW School of Medicine and Health Sciences (SMHS) and the GW School of Engineering and Applied Science (SEAS), has immediate groundbreaking potential in the treatment of Atrial Fibrillation (AF), the most common irregular heartbeat affliction in the U.S.

BOSTON/WASHINGTON The George Washington University (GW) and Allied Minds, Inc., a premier U.S. investment firm, are pleased to announce the formation of LuxCath LLC, a medical technology company that is developing real-time lesion visualization technology based on breakthrough research from the university.

LuxCath's technology for directly visualizing tissue and lesions in real time has initial application in the treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia, or irregular heartbeat, in the U.S., affecting more than 2 million people, or about 1 in every 150 individuals. The relatively new but minimally invasive procedure used to restore the heartbeat to a normal pace, known as Radio Frequency Catheter Ablation (RFCA), optimally requires a real-time, lesion-identifying, direct visualization tool in order to be performed consistently, effectively, quickly and safely.

"We formed LuxCath to ensure that electrophysiologists are treating the right parts of the heart in atrial fibrillation patients quickly and effectively," said Dr. Omar Amirana, M.D., Managing Director for Life Sciences at Boston-based Allied Minds. "LuxCath's technology should significantly improve procedural outcomes for patients, speed up procedures, as well as minimize costly and burdensome follow-up re-treatments."

This medical innovation is based on collaborative research by Drs. Marco Mercader, M.D., a cardiologist at the GW Medical Faculty Associates (MFA) and SMHS professor; Matthew Kay, D.Sc., a biomedical engineer at the GW SEAS ; and Narine Sarvazyan, Ph.D., a physiologist, at the GW SMHS. This collaboration represents GW's growing interest in investing in research programs that may become the basis of corporate partnerships like this one with Allied Minds.

"Such partnerships are crucial to bring the benefits of collaborative research and the development of innovative technologies to those who need them; and to provide an opportunity to fully develop and provide products in the commercial market," said University Vice President for Research Leo Chalupa.

"We were impressed with the collaboration across multiple disciplines and amongst multiple schools at GW in this arena. Bringing new thinking to problem solving and cross-fertilizing ideas to optimize and apply an innovative technology to a real-world problem was particularly compelling to us. We commend GW's efforts here," commented Dr. Amirana.

Drs. Mercader, Kay and Sarvazyan have focused their research for many years on AF because effectively treating the condition is one of the biggest problems hospitals face, not just in the U.S., but around the world.

To date, monitoring tissue injury in real time remains a major limitation of current ablation approaches," said Dr. Mercader. "Detection of viability gaps between the lesions and closure of these gaps during a single radio frequency ablation would increase both the safety and efficacy of therapy. We are very excited to develop products that will significantly enhance the lives of patients."


Contact: Anne Banner
George Washington University

Related medicine news :

1. MindSpec announces Bridging Parents with Autism Science webinar series
2. Georgetown physician leads national resveratrol study for Alzheimers disease
3. James George, MD: 2012 ASH Wallace H. Coulter Award for Lifetime Achievement in Hematology
4. George Mason University researchers target breast cancer in 3 trials
5. Washingtons Life Sciences Discovery Fund awards commercialization grants
6. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
7. Washington Massage School Launches Private Practice Clinic
8. Local Woodinville Contractor, Washington State Kitchen and Bath, Combats Toxic Mold, Adhering to the Toughest Mold Protection Standards in the Nation with New Promotion
9. First Huntingtons disease center established in Washington, D.C., area
10. University of Cincinnati researchers win $3.7M grant from US Department of Defense
11. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: